Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で20.94%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 32.38Mに達しています。
割高
同社の最新のPEは-5.16で、過去3年間の水準と比較して高値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は49.70M株で、前四半期比で4.31%増加しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は1.75です。